Developing Comprehensive Risk Assessment Models for Radiopharmaceutical Development
Time: 2:30 pm
day: Conference Day Two
Details:
- Identify key regulatory, manufacturing, and distribution risks affecting the commercialization of radiopharmaceuticals
- Develop robust risk assessment frameworks that consider supply chain complexities, product quality, and regulatory compliance
- Review strategies to minimize clinical and market risks, including contingency planning and investment diversification
